Abstract: The present invention relates to a planar heating sheet, including a linear heating member including a single fiber body and a plurality of heating wires surrounding the single fiber body, wherein the heating wire includes a metal wire, an organic compound layer applied on the metal wire, and a metal oxide layer applied on the organic compound layer. Since the planar heating sheet is realized by a plurality of linear heating members each formed by coating a single fiber body with heating wires, each including a metal nanowire, an organic compound layer applied on the metal nanowire, and a metal oxide layer applied on the organic compound layer, this planar heating sheet can be naturally folded or bent like a general woven fabric, and thus can be used in a wide range.

Abstract: A heat treatment method for a membrane electrode assembly (MEA) of a fuel cell includes: placing a power supply plate on a surface of the MEA or on a surface of an assembly of the MEA and a gas diffusion layer (GDL); and performing heat treatment on a surface or interior of the power supply plate by applying power to the power supply plate.

Abstract: A bispecific antigen binding protein complex comprising a first polypeptide comprising a first antigen binding site at an N terminus; a second polypeptide comprising a second antigen binding site at an N terminus; and a linker connecting the first polypeptide and the second polypeptide; wherein the linker comprises a tag at one terminus thereof, and wherein the tag is connected to a C-terminus of the first polypeptide or to an N-terminus of the second polypeptide, and comprises a cleavable amino acid sequence; as well as related compositions and methods.

Abstract: An optical phased array (OPA) may be included in a light detection and ranging (LiDAR) system and may be configured to perform beam steering. The OPA may include a cascading structure of splitters configured to enable a branch operation to be performed M times. Each splitter may split an input optical signal in a ratio of 1:1 and output the split input optical signal. The OPA may include a plurality of sets of first phase shifters (PSs), each set of first PSs located exclusively on one output end of a separate splitter, each set of first PSs including a particular quantity of first PSs based on a branch position at which the separate splitter is located. The OPA may be included in a LiDAR system that is further included in a vehicle that is configured to enable navigation of the vehicle, including autonomous navigation, through an environment.

Abstract: A method for providing a Graphic User Interface (GUI) associated with execution of an application in a mobile terminal supporting a multi-tasking function, and an apparatus implementing the same. The method for providing (GUI) in a mobile terminal, preferably includes: displaying an application execution icon region and application execution screen region configured by one or more application execution icons; receiving selection of one from the one or more application execution icons; and displaying a reduction mode execution screen of an application corresponding to the selected application execution icon on the application execution screen region. When using a multi-tasking function of a mobile terminal, the user can view a plurality of application execution screens on one screen, and input an operating command for a plurality of applications on one screen.

Abstract: A protein complex comprising (i) a first fusion protein comprising (a) a first polypeptide that comprises a first antigen-binding site and (b) a first binding protein linked to a terminus of the first polypeptide; and (ii) a second fusion protein comprising (a) a second polypeptide that comprises a second antigen-binding site and (b) a second binding protein linked to a terminus of the second polypeptide, wherein the protein complex comprises an amino acid sequence that enables cleavage between the first polypeptide and the first binding protein, and/or between the second polypeptide and the second binding protein, as well as a method for preparing a bi-specific antibody and related methods and compositions.

Abstract: Provided is an anti-Her3 antibody or antigen-binding fragment thereof, an anti-c-Met/anti-Her3 bispecific antibody including the same, and a method of preventing and/or treating a cancer using the same.

Abstract: A fusion polynucleotide including a murine CMV promoter and an intron, a recombinant vector including the fusion polynucleotide and a gene encoding a polypeptide of interest, a recombinant cell including the recombinant vector, and a method of producing a polypeptide of interest using the recombinant vector and/or the recombinant cell.

Abstract: A bispecific chimeric protein including a designed ankyrin repeat protein (DARPin), and an IgG antibody, an scFv-Fc antibody fragment, or a combination thereof, linked to the DARPin; a method for treating or preventing cancer using the same; and related methods and compositions.

Abstract: Provided is a method of screening a target-specific antibody for an antigen that undergoes structural change in a particular physiological condition.

Abstract: A fusion polynucleotide including a human CMV promoter and an intron, a recombinant vector including the fusion polynucleotide and a gene encoding a polypeptide of interest, a recombinant cell comprising the recombinant vector, and a method of producing a polypeptide of interest using the recombinant vector or recombinant cell.

Abstract: Provided is an anti-Her3 antibody or antigen-binding fragment thereof, an anti-c-Met/anti-Her3 bispecific antibody including the same, and a method of preventing and/or treating a cancer using the same.

Abstract: A startup limitation method for a fuel cell vehicle. In particular, a sensor is used to determine whether or not a hydrogen inlet door of the fuel cell vehicle is opened. When the hydrogen inlet door is opened, shutting down the fuel cell vehicle. A pressure of a hydrogen storage tank of the fuel cell vehicle is measured, and in response, the fuel cell vehicle is shut down when an increase of the pressure of the hydrogen storage tank of the fuel cell vehicle exceeds a predetermined pressure variation range if the fuel cell vehicle has not already been shut down due to the hydrogen inlet door of the fuel cell vehicle being opened.

Abstract: A bispecific chimeric protein including a designed ankyrin repeat protein (DARPin), and an IgG antibody, an scFv-Fc antibody fragment, or a combination thereof, linked to the DARPin; a method for treating or preventing cancer using the same; and related methods and compositions.

Abstract: Provided is a method of screening a target-specific antibody for an antigen that undergoes structural change in a particular physiological condition.

Abstract: A bispecific antigen binding protein complex comprising a first polypeptide comprising a first antigen binding site at an N terminus; a second polypeptide comprising a second antigen binding site at an N terminus; and a linker connecting the first polypeptide and the second polypeptide; wherein the linker comprises a tag at one terminus thereof, and wherein the tag is connected to a C-terminus of the first polypeptide or to an N-terminus of the second polypeptide, and comprises a cleavable amino acid sequence; as well as related compositions and methods.

Abstract: Provided is a protein complex including a bi-specific antibody, and a method of preparing the protein complex, which can provide a system that simultaneously targets two antigens.

Abstract: A protein complex comprising (i) a first fusion protein comprising (a) a first polypeptide that comprises a first antigen-binding site and (b) a first binding protein linked to a terminus of the first polypeptide; and (ii) a second fusion protein comprising (a) a second polypeptide that comprises a second antigen-binding site and (b) a second binding protein linked to a terminus of the second polypeptide, wherein the protein complex comprises an amino acid sequence that enables cleavage between the first polypeptide and the first binding protein, and/or between the second polypeptide and the second binding protein, as well as a method for preparing a bi-specific antibody and related methods and compositions.

Abstract: A polypeptide inhibiting binding between vascular endothelial growth factor receptor-2 and a vascular endothelial growth factor, a fusion protein including the same, and a method of preparing the fusion protein are disclosed.

Abstract: An antibody specifically binding to angiopoietin-2, and antigen-binding fragments thereof, and a use thereof are disclosed.